Related Experiment Video
Updated: Jul 9, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
The role of N-methyladenosine modification in acute and chronic kidney diseases
Saiqi Qi1, Jie Song1, Linjun Chen2
1The College of Medical Technology, Shanghai University of Medicine & Health Sciences, 279 Zhouzhu Highway, Pudong New Area, Shanghai, 201318, People's Republic of China.
Abstract:
N6-methyladenosine (m6A) modification is a kind of RNA modification in which methylation occurs at the sixth N position in adenosine in RNA, which can occur in various RNAs such as mRNAs, lncRNAs and miRNAs. This is one of the most prominent and frequent posttranscriptional modifications within organisms and has been shown to function dynamically and reversibly in a variety of ways, including splicing, export, attenuation and translation initiation efficiency to regulate RNA expression. There are three main enzymes associated with m6A modification: writers, readers and erasers. Increasing evidence has shown that m6A modification is associated with the onset and development of kidney disease. In this article, we address the important physiological and pathological roles of m6A modification in kidney diseases (uremia, ischemia-reperfusion kidney injury, drug-induced kidney injury, and diabetic nephropathy) and its molecular mechanisms to provide reference for the diagnosis and clinical management of kidney diseases.
Insights
N6-methyladenosine (m6A) RNA modification is crucial in regulating gene expression and is increasingly linked to kidney diseases. This review explores m6A
Area of Science:
- Epigenetics
- Molecular Biology
- Nephrology
Background:
- N6-methyladenosine (m6A) is a prevalent RNA modification impacting gene expression.
- m6A dynamics involve writers, readers, and erasers.
- m6A dysregulation is implicated in various kidney pathologies.
Purpose of the Study:
- To review the physiological and pathological roles of m6A modification in kidney diseases.
- To elucidate the molecular mechanisms of m6A in kidney disease development.
- To provide insights for clinical diagnosis and management of kidney diseases.
Main Methods:
- Literature review of studies on m6A modification and kidney diseases.
- Analysis of molecular mechanisms underlying m6A's role in renal pathophysiology.
- Synthesis of current evidence on m6A in uremia, I/R injury, drug-induced injury, and diabetic nephropathy.
Main Results:
- m6A modification plays significant roles in splicing, RNA export, translation, and stability.
- m6A is involved in the pathogenesis of uremia, ischemia-reperfusion kidney injury, drug-induced kidney injury, and diabetic nephropathy.
- Specific m6A 'writers', 'readers', and 'erasers' are key players in kidney disease progression.
Conclusions:
- m6A modification is a critical regulator in kidney disease.
- Targeting m6A pathways offers potential therapeutic strategies for kidney diseases.
- Further research into m6A mechanisms can improve kidney disease diagnosis and treatment.
More Related Videos
08:56A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
Related Concept Videos
Nephrons
RNA Editing
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
RNA Stability
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....